NS Pharma, Inc
On behalf of our parent company, Nippon Shinyaku Co., Ltd, we are seeking in-licensing opportunities in the therapeutic areas of Hematology, Orphan diseases and external innovation opportunities in the new modality approaches.
)
January 11-14, 2027 | San Francisco
January 11-14, 2027 | San Francisco
)
)
January 11-14, 2027 | San Francisco
){kind=logo}
)